The CDMO’s Module 1 commercial production facility to be operational by summer 2026 Hyderabad, March 9th 2026: Neuland Laboratories  will open its new commercial peptide facility in the summer of 2026 ...

Loti Labs Pioneers Quality in GHRP-6 Research Tampa, United States - March 1, 2026 / Loti Labs / Loti Labs, a prominent ...

A team at ETH Zurich developed a new peptide-based organocatalyst that handles macrocycle formation from start to finish.

Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by ...

Loti Labs produces GHRP-6 peptides to research-grade specifications, ensuring they meet the exact composition required for controlled and repeatable experimental outcomes. Each batch is meticulously ...

Fortunately, these giant rings are about to become a lot easier to access. Helma Wennemers and her team at ETH Zurich have ...

Neuland Laboratories Ltd. plans to open a commercial‑scale peptide manufacturing facility in summer 2026 at its 17‑acre Bonthapally campus in Hyderabad.

Vapourtec's Peptide-Builder, a fully automated, high-throughput benchtop peptide synthesizer, has been designed to redefine solid-phase peptide synthesis (SPPS). Compact, efficient and intuitive, it ...

Amide Technologies has raised $16.5 million in venture capital to help commercialize its peptide production process. The process was developed from 2011 to 2017 in the lab of the Massachusetts ...

What is it? As the name suggests, nonribosomal peptide synthesis (NRPS) generates polypeptides sans ribosome. The resultant peptides, generally short oligomers of two to perhaps 48 residues, are not ...